General Announcement::ASX:TLX; Nasdaq:TLX - Telix Achieves FY25 Guidance - US$804M, Q4 Growth

Issuer & Securities

Issuer/ Manager
TELIX PHARMACEUTICALS LIMITED
Securities
TELIXPHAR A$650M2.375%N290730 - XS2862961492 - JWQB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
20-Jan-2026 14:13:54
Status
New
Announcement Sub Title
ASX:TLX; Nasdaq:TLX - Telix Achieves FY25 Guidance - US$804M, Q4 Growth
Announcement Reference
SG260120OTHRB4IB
Submitted By (Co./ Ind. Name)
Genevieve Ryan
Designation
Company Secretary
Effective Date and Time of the event
20/01/2026 17:00:00
Description (Please provide a detailed description of the event in the box below)
ASX:TLX; Nasdaq:TLX - Telix Achieves FY25 Guidance - US$804M, Q4 Growth

Attachments

20260120 Q4 Business update vFINAL.pdf
Total size =327K